Grasim Industries Board Approves Q3FY26 Unaudited Financial Results

1 min read     Updated on 11 Feb 2026, 02:56 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Grasim Industries Limited's Board of Directors approved unaudited financial results for the quarter and nine months ended December 31, 2025, during a meeting held February 10, 2026. The approval followed Audit Committee recommendations and included Limited Review Reports from auditors. The company fulfilled regulatory obligations under SEBI Listing Regulations, communicating the outcome to BSE and NSE exchanges.

32347583

*this image is generated using AI for illustrative purposes only.

Grasim Industries Limited has announced the approval of its unaudited financial results for the third quarter of fiscal year 2026, marking a significant milestone in the company's regulatory compliance and financial reporting obligations.

Board Meeting Details

The Board of Directors convened on February 10, 2026, to review and approve the company's financial performance. The meeting was conducted with proper adherence to regulatory requirements and corporate governance standards.

Meeting Parameter: Details
Meeting Date: February 10, 2026
Start Time: 3:25 p.m. (IST)
End Time: 5:24 p.m. (IST)
Duration: Approximately 2 hours

Financial Results Approval

The board approved the unaudited financial results for both standalone and consolidated operations, covering the quarter and nine months ended December 31, 2025. This approval came following thorough review and recommendations from the Audit Committee, ensuring proper oversight and governance.

The financial results were accompanied by Limited Review Reports from the company's auditors, providing additional assurance on the financial information presented. The approval process demonstrates the company's commitment to maintaining transparency and regulatory compliance.

Regulatory Compliance

The announcement was made in compliance with multiple SEBI regulations and circulars:

  • Regulations 30, 33, 52 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026

The company has fulfilled its obligation to inform stock exchanges and stakeholders about the outcome of the board meeting, maintaining its commitment to transparent corporate governance practices.

Stock Exchange Communication

Grasim Industries communicated the board meeting outcome to both major Indian stock exchanges where its shares are listed:

Exchange: Trading Details
BSE Limited: Scrip Code 500300
National Stock Exchange: Symbol GRASIM

The company also copied relevant international entities including Luxembourg Stock Exchange and Citibank N.A. for depositary receipt services, reflecting its global presence and compliance requirements.

Historical Stock Returns for Grasim Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-0.72%+4.40%+5.61%+8.95%+18.57%+139.10%

Grasim Industries Reports No Deviation in Rights Issue Fund Utilization for Q3FY26

2 min read     Updated on 11 Feb 2026, 12:13 AM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Grasim Industries Limited submitted its Q3FY26 monitoring agency report confirming no deviation in the utilization of its ₹3,999.80 crore rights issue proceeds. The company utilized ₹0.65 crore during the quarter for general corporate purposes, maintaining ₹0.21 crore in unutilized funds. CARE Ratings Limited certified full regulatory compliance with SEBI requirements.

32294631

*this image is generated using AI for illustrative purposes only.

Grasim Industries Limited has filed its quarterly monitoring agency report for the period ended December 31, 2025, confirming compliance with regulatory requirements and no deviation in fund utilization from its rights issue proceeds. The report was submitted to BSE Limited and National Stock Exchange of India Limited on February 10, 2026.

Rights Issue Overview

The company's rights issue, conducted from January 17, 2024, to January 29, 2024, raised ₹3,999.80 crore through the allotment of 2,20,70,910 equity shares at ₹1,812 per share. CARE Ratings Limited serves as the monitoring agency for tracking the utilization of these proceeds.

Parameter: Details
Issue Period: January 17, 2024 to January 29, 2024
Issue Size: ₹3,999.80 crore
Offer Price: ₹1,812 per share
Shares Allotted: 2,20,70,910
Monitoring Agency: CARE Ratings Limited

Fund Utilization Progress

The monitoring report reveals that during Q3FY26, the company utilized ₹0.65 crore from the rights issue proceeds specifically for general corporate purposes, primarily towards salary payments. The total amount allocated for general corporate purposes in the offer document was ₹977.65 crore.

Utilization Category: Allocated Amount (₹ Crore) Utilized Till Q3FY26 (₹ Crore) Unutilized Amount (₹ Crore)
Debt Repayment: 3,000.00 3,000.00 -
General Corporate Purposes: 977.65 971.11 0.21
Total: 3,977.65 3,971.11 0.21

Monitoring Account Status

As of December 31, 2025, the company maintains ₹0.14 crore in its Axis Bank monitoring account. The report indicates that while unutilized general corporate purpose proceeds stand at ₹0.21 crore, the actual monitoring account balance is lower due to the utilization of issue expense proceeds towards general corporate purposes in Q4FY25.

Regulatory Compliance

The monitoring agency report confirms full compliance with SEBI regulations, specifically Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Regulation 82(4) of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The report was verified by Nerkar & Co., a peer-reviewed audit firm, through their certificate dated February 03, 2026.

Key Confirmations

The monitoring agency report provides several key confirmations regarding the rights issue proceeds:

  • All utilization aligns with disclosures in the offer document
  • No material deviations from expenditures disclosed in the offer document
  • No changes in the means of finance for disclosed objects
  • No major deviations observed from earlier monitoring reports
  • No unfavorable events affecting the viability of stated objects

The company's promoter shareholding increased from 42.75% as of December 31, 2023, to 43.22% as of December 31, 2025, following the rights issue. The report confirms that there remains a pending amount of ₹5.01 crore to be collected from investors, with the company having until March 2027 to utilize the net proceeds according to the offer document terms.

Historical Stock Returns for Grasim Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-0.72%+4.40%+5.61%+8.95%+18.57%+139.10%

More News on Grasim Industries

1 Year Returns:+18.57%